Farron Bennett
Surgical · Hamilton, NYNPI 1518032044
Payments from drug & device makers
Across 316 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$878
- Lilly USA, LLC$655
- AbbVie$469
- Merck$459
- Pfizer$432
- Boehringer Ingelheim$342
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,460100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 59 | $878 |
| Lilly USA, LLC | 41 | $655 |
| AbbVie | 28 | $469 |
| Merck | 22 | $459 |
| Pfizer | 39 | $432 |
| Boehringer Ingelheim | 11 | $342 |
| AstraZeneca | 9 | $289 |
| GSK | 15 | $252 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $165 |
| Exact Sciences | 8 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $162 |
| Amneal Pharmaceuticals LLC | 6 | $154 |
| Astellas Pharma US Inc | 6 | $140 |
| Amgen | 7 | $117 |
| Mylan Specialty L.p. | 6 | $110 |
| Bausch Health US, LLC | 4 | $86 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $70 |
| Antares Pharma, Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 4 | $63 |
| Lundbeck LLC | 3 | $58 |
| Baxter Healthcare | 2 | $52 |
| Tolmar, Inc. | 3 | $52 |
| Halozyme Inc | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 2 | $28 |
| Abbott | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Phadia US Inc. | 1 | $15 |
| Shield Therapeutics Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$124
How this compares
$5,460 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 86 | $97,088 |
| MounjaroTirzepatide | 59 | $65,071 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 85 | $59,516 |
| XifaxanRifaximin | 16 | $51,279 |
| OzempicSemaglutide | 28 | $30,045 |
| EliquisApixaban | 37 | $25,437 |
| TrulicityDulaglutide | 13 | $25,060 |
| JanuviaSitagliptin Phosphate | 11 | $12,626 |
| MyrbetriqMirabegron | 16 | $11,411 |
| TrintellixVortioxetine Hydrobromide | 11 | $6,406 |
| Varenicline Tartrate | 18 | $5,184 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 89 | $3,582 |
| Levothyroxine Sodium | 173 | $2,506 |
| Omeprazole | 221 | $2,499 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $2,237 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $342 | $97,08886 claims |
| Lilly USA, LLCMounjaro, Trulicity | $655 | $90,13172 claims |
| GSKTrelegy Ellipta | $252 | $59,51685 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $70 | $51,27916 claims |
| Novo NordiskOzempic | $878 | $30,04528 claims |
| PfizerEliquis | $432 | $25,43737 claims |
| MerckJanuvia | $459 | $12,62611 claims |
| Astellas Pharma US IncMyrbetriq | $140 | $11,41116 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $162 | $6,40611 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $154 | $2,506173 claims |
| AbbVieSynthroid | $469 | $1,50413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,544 surgical providers in New York.
Other surgical in Hamilton
- Lindsay SchweikarthAlbany$324K
- Nicole FeinNew York$225K
- Kenneth RuizNew York$93K
- Sarah MartineckWilliamsville$87K
- Terry LinNew York$70K
- Beth PhillipsEast Syracuse$51K
- James DoolittleNew York$46K
- Tanya GeistAmherst$43K
- Irina KommNew York$39K
- Alexandra DemeglioNew York$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.